Navigation Links
Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM)
Date:10/14/2008

ter, show a good one-year clinical outcome regarding major adverse cardiac events, including a low incidence of stent thrombosis.

In the study, 236 patients were treated with Genous and completed 12-month follow-up. For the lesions treated, 64% were type B2 or C, 16% were chronic total occlusion, and 23% were bifurcated. The TLR rate was 8.1%, and the MACE rate was 13.6%. There was one patient with acute stent thrombosis at 24 hours, two patients with SAT at seven and 18 days, and no LST observed.

Unlike drug-eluting stents, Genous, which is coated with an antibody, captures a patient's endothelial progenitor cells (EPCs) to accelerate the natural healing process. EPCs circulate in the bloodstream and are involved in the repair of blood vessels. When attracted to the surface of Genous, EPCs rapidly form an endothelial layer over the stent that provides protection against thrombus and minimizes restenosis.

OrbusNeich designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. The company's product portfolio includes the Genous Bio-engineered R stent, an antibody-coated device that is the first-ever stent to capture a patient's endothelial progenitor cells (EPCs) to accelerate the natural healing process following placement. Other products are stents, balloons and guiding catheters marketed under the names of Blazer(TM), R stent(TM), Scoreflex(TM), Sapphire(TM), Sapphire(TM) NC, Avita(TM), Avita HP(TM), SafeCut(TM), Lumina(TM) and Saffron.

A global company, OrbusNeich is headquartered in Hong Kong and has operations in Fort Lauderdale, Fla.; Hoevelaken, The Netherlands; Tokyo; and Shenzhen, China. OrbusNeich, which has provided cardiology devices to physicians through its predecessor companies since 1979, today supplies products to interventional cardiologists in more than 60 countries. For more information, visit http://www.OrbusNeich.com'/>"/>

SOURCE OrbusNeich
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
2. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
3. Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study
4. Fralex provides update on timing of interim analysis results
5. BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test
6. Xoft Showcases Interim Clincal Results for Breast Cancer Product and New Indications for Electronic Brachytherapy(eBx) at Astro Meeting
7. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
8. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
9. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
10. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
11. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Thoratec Corporation (NASDAQ: THOR ), ... to save, support and restore failing hearts, announced today ... President and Chief Executive Officer, effective immediately.  Mr. Grossman succeeds ... from his executive and Board roles but will remain ... quarter of 2016.  Mr. Grossman has ...
(Date:9/22/2014)... -- Research and Markets  has announced the addition ... 2014" report to their offering. ... a professional and in-depth study on the current state ... the Chinese situation. The report provides a ... and industry chain structure. The diclofenac market analysis is ...
(Date:9/22/2014)... , Sept. 22, 2014 China Nepstar Chain Drugstore ... leading retail drugstore chain in China based ... will hold its 2014 Annual General Meeting of Shareholders (the "AGM") ... will be held at the meeting room of the Company at ... Shenzhen , Guangdong Province 518054, ...
Breaking Medicine Technology:Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 4Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 5Global and Chinese Diclofenac Industry Report 2014 2China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 2
... 9 Avinger, Inc., a medical device company ... combat peripheral artery disease, announces the enrollment of ... OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial. ... study intended to evaluate the Wildcat Catheter,s ability ...
... (Nasdaq: PCYC ), a biopharmaceutical company focused ... the treatment of cancer and mediated diseases, today announced ... fiscal quarter and fiscal year ended June 30, 2010 ... 2010.  The company will conduct a conference call and ...
Cached Medicine Technology:First Patient Enrolled in 'CONNECT' Clinical Trial 2Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference 2
(Date:9/22/2014)... Steven Reinberg HealthDay ... Pediatricians are urging that all children aged 6 months and ... American Academy of Pediatrics updated their influenza vaccine recommendations to ... of vaccine to build immunity. The AAP also wants parents ... kids the nasal spray vaccine instead of the flu shot ...
(Date:9/22/2014)... Hamilton, ON (September 22, 2014) McMaster scientists have ... a new class of antibiotics. , Although dozens ... looked at how a certain part of bacteria are ... stopping it. , The discovery is important as ... is making the cures for infections ineffective. The World ...
(Date:9/22/2014)... Madison, WI (PRWEB) September 22, 2014 ... companies in the United States, promotes National ... company believes that all individuals should have access ... function in aging. , The demand for products ... living longer than ever before. For over six ...
(Date:9/22/2014)... 2014 (HealthDay News) -- Scans of young children,s ... read. This finding could potentially allow doctors to ... early on, preliminary research suggests. "Early identification ... dyslexia as well as most neurodevelopmental disorders," the ... professor of child and adolescent psychiatry at University ...
(Date:9/22/2014)... Nanuet, NY (PRWEB) September 22, 2014 ... Blindness, Rockland Chrysler Jeep Dodge Ram is launching an ... Blind Egg Challenge (#blindeggchallenge or #ffbBEC) aims to raise ... Egg Challenge involves throwing an egg in the air ... at least three others and if a nominee does ...
Breaking Medicine News(10 mins):Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 2Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 3Health News:Quincy Bioscience Promotes National Self-Improvement Month 2Health News:Can Brain Scans Help Predict Young Children's Reading Abilities? 2Health News:Blind Egg Challenge Raises Awareness for Foundation Fighting Blindness 2
... from the Virginia Bioinformatics Institute (VBI) at Virginia Tech ... virulence proteins in oomycete plant pathogens that enables the ... protein region contains the amino acid sequence motifs RXLR ... virulence proteins across the membrane surrounding plant cells without ...
... concerns often go unspoken and ... unaddressed., ... patients frequently do not raise all of,their concerns about proposed procedures. A ... Joint Surgery found that patients age,60 or older have many concerns and ...
... World Congress on Interventional Therapies for Type 2 Diabetes ... and public health to discuss the role of surgery ... 2 diabetes. The World Congress has been formed to ... for health care systems and patient care. , Led ...
... Edouard Approaches, WASHINGTON, Aug. 4 Hurricane season ... the Gulf of Mexico and,Hurricane Dolly having just left. ... needs of people whose homes were flooded and damaged ... prepare for,potential hurricane conditions along the coasts of Louisiana ...
... Chan, and presidents from Africa and Latin,America call for ... with,men, MEXICO CITY, Aug. 4 A day ... Organization called attention to,the need to combat AIDS among ... first comprehensive report exposing the failure of governments and,global ...
... LAFAYETTE, Ind. - The methods mothers use to control their ... negative impact on their child,s self-esteem and behavior, according to ... parents how to interact with their children based on one ... have a propensity for being verbally aggressive have a tendency ...
Cached Medicine News:Health News:Key to virulence protein entry into host cells discovered 2Health News:Video: Communication is Key to Ease Worry about Orthopaedic Surgery 2Health News:Video: Communication is Key to Ease Worry about Orthopaedic Surgery 3Health News:1st World Congress On Interventional Therapies for Type 2 Diabetes 2Health News:1st World Congress On Interventional Therapies for Type 2 Diabetes 3Health News:1st World Congress On Interventional Therapies for Type 2 Diabetes 4Health News:American Red Cross on the Gulf Coast: Storms Coming and Going 2Health News:American Red Cross on the Gulf Coast: Storms Coming and Going 3Health News:As AIDS Conference Opens, amfAR Releases Report Exposing Global Failure to Address HIV Among MSM 2Health News:As AIDS Conference Opens, amfAR Releases Report Exposing Global Failure to Address HIV Among MSM 3Health News:Study: verbal aggression may affect children's behavior 2
Cloward Dowel CL18 Used for Anterior Cervical Fusion and are preserved by Freeze-dried method....
8 mm S Graftech cervical spacer....
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
... is a useful addition to ... It may be used in ... and orbital regions in all ... strength over the Leibinger Micro ...
Medicine Products: